Latest Breaking News On - Romain didier - Page 1 : vimarsana.com
Lower Post-TAVR Mortality Seen on DOAC vs VKA When OAC Indicated
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
DOACs May Have Advantage Over VKAs After TAVI, Study Hints
tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.
Neovasc Inc.: Neovasc Announces First Neovasc Reducer Implants in France
Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - December 15, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ( Neovasc or the Company ) announced today that it has completed the first three Neovasc Reducer ( Reducer ) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina.
The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain Didier, Brest University Hospital, France. Prof. Stefan Verheye, Interventional Cardiologist at the Antwerp Cardiovascular Center in Middelheim, Belgium, provided support for the procedures. Refractory angina is a difficult burden for many French patients despite medical therapy or invasive procedures, said Prof. Gilard. I m gratified that we were able to offer the Reducer treatment for t
Share:
VANCOUVER and MINNEAPOLIS, Dec. 15, 2020 (GLOBE NEWSWIRE) via
NewMediaWire Neovasc Inc. ( Neovasc or the Company ) (NASDAQ, TSX: NVCN) announced today that it has completed the first three Neovasc Reducer™ ( Reducer ) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina.
The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain Didier, Brest University Hospital, France. Prof. Stefan Verheye, Interventional Cardiologist at the Antwerp Cardiovascular Center in Middelheim, Belgium, provided support for the procedures. Refractory angina is a difficult burden for many French patients despite medical therapy or invasive procedures, said Prof. Gilard. I m gratified that we were able to offer the Reducer treatment for the first time in France.
vimarsana © 2020. All Rights Reserved.